REQUIP ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	21
309	Progressive myoclonus epilepsy	1

6. Parkinson disease

Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

diseases per page:

Showing 1 to 10 of 21 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-002827-17-EE (EUCTR)	23/04/2013	08/02/2013	A fixed dose, dose response study for ropinirole prolonged release (PR) in patients with early stage ...	A fixed dose, dose response study for ropinirole prolonged release (PR) in patients with early stage ...	Early stage Parkinson's Disease. MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: P ...	Trade Name: REQUIP-MODUTAB , 2mg Product Name: ropinirole PR, 2mg Product Code: SK&F101468 INN or Propo ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	210		United States;Estonia;Slovakia;Russian Federation;Korea, Republic of
2	EUCTR2011-002828-41-EE (EUCTR)	23/04/2013	08/02/2013	A study to test the effectiveness of varying doses of ropinirole PR while taking L-dopa in patients ...	A fixed dose, dose-response study of ropinirole prolonged release (PR) as adjunctive treatment to L- ...	Advanced Parkinson's disease. MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Park ...	Trade Name: REQUIP-MODUTAB, 2mg Product Name: ropinirole PR, 2mg Product Code: SK&F101468 INN or Propos ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	406		United States;Taiwan;Estonia;Slovakia;Argentina;Chile;Russian Federation;Korea, Republic of
3	EUCTR2011-002828-41-SK (EUCTR)	27/03/2013	04/03/2013	A study to test the effectiveness of varying doses of ropinirole PR while taking L-dopa in patients ...	A fixed dose, dose-response study of ropinirole prolonged release (PR) as adjunctive treatment to L- ...	Advanced Parkinson's disease. MedDRA version: 16.0;Level: PT;Classification code 10061536;Term: Park ...	Trade Name: RequipModutab, 2mg Product Name: ropinirole PR, 2mg Product Code: SK&F101468 INN or Propose ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	406		United States;Estonia;Taiwan;Slovakia;Argentina;Chile;Russian Federation;Korea, Republic of
4	EUCTR2012-000801-64-GB (EUCTR)	09/02/2013	26/11/2012	A study of the effects of medication on memory in Parkinson's Disease	A Phase IV Acceptability and Feasibility Trial of the Effects of Medication on Memory in Idiopathic ...	Idiopathic Parkinson's Disease MedDRA version: 17.0;Level: LLT;Classification code 10013113;Term: Di ...	Trade Name: Mirapexin extended release various strengths Product Name: Pramipexole dihydrochloride mo ...	University Hospital of North Staffordshire	Keele University	Not Recruiting			Female: yes Male: yes	55	Phase 4	United Kingdom
5	NCT01536574 (ClinicalTrials.gov)	September 2, 2010	19/1/2012	Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528	An Open Label Extension Study With REQUIP PR for Subjects From Study ROP111528	Parkinson Disease	Drug: Requip PR	GlaxoSmithKline	NULL	Completed	30 Years	N/A	All	295	Phase 3	China
6	NCT01154166 (ClinicalTrials.gov)	February 15, 2010	29/6/2010	A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatm ...	A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatm ...	Parkinson Disease	Drug: ReQuip PR;Drug: Placebo	GlaxoSmithKline	NULL	Completed	30 Years	N/A	All	347	Phase 3	China
7	NCT01371682 (ClinicalTrials.gov)	September 18, 2009	10/6/2010	A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Rel ...	An Open Label Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole P ...	Parkinson Disease	Drug: Ropinirole XL	GlaxoSmithKline	NULL	Completed	18 Years	50 Years	All	50	Phase 1	Belgium
8	EUCTR2009-012529-12-FR (EUCTR)	10/06/2009	18/05/2009	A randomised, REQUIP® IR-controlled, n-of-1, multiple crossover, pilot trial of the effect of REQUIP ...	A randomised, REQUIP® IR-controlled, n-of-1, multiple crossover, pilot trial of the effect of REQUIP ...	parkinson's disease MedDRA version: 9.1;Level: LLT;Classification code 10013113;Term: Disease Parkin ...	Trade Name: REQUIP-LP Product Name: ropinirole Trade Name: REQUIP Product Name: ropinirole	CHU de Toulouse	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	10		France
9	EUCTR2009-015833-66-IT (EUCTR)	20/01/2009	18/04/2012	Ropinirole 24h prolonged release and motor fluctuations: a study to control the wearing-off induced ...	Ropinirole 24h prolonged release and motor fluctuations: a study to control the wearing-off induced ...	Parkinson's Disease MedDRA version: 14.1;Level: LLT;Classification code 10013113;Term: Disease Parki ...	Trade Name: REQUIP*28CPR 8MG R.P. INN or Proposed INN: ROPINIROLE Other descriptive name: NA Trade Name ...	CASA DI CURA PRIVATA S.RAFFAELE - PISANA	NULL	Not Recruiting			Female: yes Male: yes			Italy
10	NCT00485069 (ClinicalTrials.gov)	June 2007	11/6/2007	REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study	Post-Marketing Clinical Study of REQUIP(Ropinirole Hydrochloride) Tablets in Patients With Parkinson ...	Parkinson Disease;Parkinson's Disease	Drug: ROP;Drug: ROP+L-Dopa	GlaxoSmithKline	NULL	Completed	20 Years	N/A	All	123	Phase 4	Japan

First Previous1 2 3Next Last

309. Progressive myoclonus epilepsy

Clinical trials : 11 / Drugs : 15 - (DrugBank : 2) / Drug target genes : 4 - Drug target pathways : 9

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2007-003210-33-FI (EUCTR)	03/08/2007	13/06/2007	Effect of ropinirole hydrochloride in progressive myoclonic epilepsy of Unverricht–Lundborg type	Effect of ropinirole hydrochloride in progressive myoclonic epilepsy of Unverricht–Lundborg type	Progressive myoclonus epilepsy of the Unverricht–Lundborg disease (ULD) type MedDRA version: 9.1;Lev ...	Trade Name: Requip Product Name: Ropinirole hydrochloride Other descriptive name: ROPINIROLE HYDROCHLO ...	Department of Neurology, Turku University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	15		Finland

First Previous1Next Last